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Prior research has demonstrated that clinical research
trial participants are often unable to differentiate between
experimental and conventional care.3 TM research shows
that some research participants consent to participating
in a clinical research trial without fully understanding 
the research process.4 To protect the rights of participants 
in clinical research trials, researchers should ensure that 
participants fully understand what it means to be in a 
clinical research trial so they can make informed decisions 
about whether or not to participate.
Therapeutic Misconception and Scientific Reframing is 
a National Institute of Mental Health funded study led by 
Charles Lidz, Ph.D. The study’s goals are to:
 • Develop an innovative procedure that educates 
participants about clinical research trials to reduce 
TM; and
 • Test this innovative procedure in a hypothetical 
clinical research trial to reduce TM without reducing 
study enrollment rates.
Methodology/Design
Study participants were randomly divided into two groups: 
an experimental group and a control group. Members of 
each group watched a narrated educational Power Point 
presentation about the hypothetical clinical research trial 
they were being asked to pretend to consent to. Members of 
the experimental group watched an additional presentation 
explaining exactly what a clinical research trial is, and how 
participating in a clinical research trail may be different than 
receiving conventional care. 
 
After viewing the presentation(s), all study participants 
completed a survey that included background information, a 
measure of TM, and the participant’s decision about whether 
they would agree to participate in the hypothetical clinical 
research trial they learned about during the presentation(s). 
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History/Background
“Therapeutic misconception” (TM) describes when a 
clinical research trial participant fails to understand 
the difference between participating in a clinical trial 
versus receiving  conventional treatment, i.e., treatment 
as usual.1-2 Individuals experiencing TM mistakenly 
assume that by enrolling in a clinical research trial they 
will receive the latest experimental treatment, without 
understanding the differences including that they will 
be randomly assigned to either an experimental or a 
conventional control group.1-2 Patients in conventional 
treatment receive personalized treatment plans, 
which allow for treatment changes that are best for a 
particular patient. Conversely, patients in clinical trials 
receive treatment controlled by a strict clinical research 
protocol.
Preliminary Outcomes/Future Impact
Preliminary analyses show no significant differences 
between the groups regarding their decision about whether 
or not to participate in the hypothetical clinical research 
trial. However, results indicate a statistically significant 
difference in TM scale scores, suggesting experimental 
group participants were less likely to experience TM. This 
suggests that including a brief educational presentation 
about the purpose, nature, and design of clinical research 
trials during the informed consent process does not 
negatively impact recruitment, and can help reduce TM. 
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